231 related articles for article (PubMed ID: 30959742)
1. Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase.
Tokumaru Y; Tajirika T; Sugito N; Kuranaga Y; Shinohara H; Tsujino T; Matsuhashi N; Futamura M; Akao Y; Yoshida K
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959742
[TBL] [Abstract][Full Text] [Related]
2. DEAD-Box Protein RNA-Helicase DDX6 Regulates the Expression of HER2 and FGFR2 at the Post-Transcriptional Step in Gastric Cancer Cells.
Tajirika T; Tokumaru Y; Taniguchi K; Sugito N; Matsuhashi N; Futamura M; Yanagihara K; Akao Y; Yoshida K
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29987267
[TBL] [Abstract][Full Text] [Related]
3. Oncogene RNA helicase DDX6 promotes the process of c-Myc expression in gastric cancer cells.
Taniguchi K; Iwatsuki A; Sugito N; Shinohara H; Kuranaga Y; Oshikawa Y; Tajirika T; Futamura M; Yoshida K; Uchiyama K; Akao Y
Mol Carcinog; 2018 May; 57(5):579-589. PubMed ID: 29314290
[TBL] [Abstract][Full Text] [Related]
4. DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells.
Iio A; Takagi T; Miki K; Naoe T; Nakayama A; Akao Y
Biochim Biophys Acta; 2013 Oct; 1829(10):1102-10. PubMed ID: 23932921
[TBL] [Abstract][Full Text] [Related]
5. The microRNA-21/PTEN pathway regulates the sensitivity of HER2-positive gastric cancer cells to trastuzumab.
Eto K; Iwatsuki M; Watanabe M; Ida S; Ishimoto T; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Baba H
Ann Surg Oncol; 2014 Jan; 21(1):343-50. PubMed ID: 24154840
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
7. miR-216b Post-Transcriptionally Downregulates Oncogene KRAS and Inhibits Cell Proliferation and Invasion in Clear Cell Renal Cell Carcinoma.
Wang Y; Dong D; Jiang S; Zhang E; Zheng W; Mao L; Li W; Zhou J; Fan L; Cheng R; Li Z; Fang Z; Gui Y; Li X
Cell Physiol Biochem; 2018; 49(5):1755-1765. PubMed ID: 30231239
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of miR-802 suppresses gastric cancer oncogenicity via targeting RAB23 expression.
Zhang XY; Mu JH; Liu LY; Zhang HZ
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4071-4078. PubMed ID: 29028094
[TBL] [Abstract][Full Text] [Related]
9. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
[TBL] [Abstract][Full Text] [Related]
10. Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine.
Hu N; Yin JF; Ji Z; Hong Y; Wu P; Bian B; Song Z; Li R; Liu Q; Wu F
Cell Physiol Biochem; 2017; 44(6):2158-2173. PubMed ID: 29241186
[TBL] [Abstract][Full Text] [Related]
11. miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesis.
Huang T; Kang W; Zhang B; Wu F; Dong Y; Tong JH; Yang W; Zhou Y; Zhang L; Cheng AS; Yu J; To KF
Mol Cancer; 2016 Jan; 15():9. PubMed ID: 26801246
[TBL] [Abstract][Full Text] [Related]
12. miR-5590-3p inhibited tumor growth in gastric cancer by targeting DDX5/AKT/m-TOR pathway.
Wu N; Han Y; Liu H; Jiang M; Chu Y; Cao J; Lin J; Liu Y; Xu B; Xie X
Biochem Biophys Res Commun; 2018 Sep; 503(3):1491-1497. PubMed ID: 30029874
[TBL] [Abstract][Full Text] [Related]
13. DEAD-box helicase 56 functions as an oncogene promote cell proliferation and invasion in gastric cancer via the FOXO1/p21 Cip1/c-Myc signaling pathway.
Wang J; Wang Y; Wang J; Zhang S; Yu Z; Zheng K; Fu Z; Wang C; Huang W; Chen J
Bioengineered; 2022 May; 13(5):13970-13985. PubMed ID: 35723050
[TBL] [Abstract][Full Text] [Related]
14. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
[TBL] [Abstract][Full Text] [Related]
15. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.
Zeng B; Shi W; Tan G
BMC Cancer; 2018 Jan; 18(1):34. PubMed ID: 29304764
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of STIL suppresses the progression of gastric cancer by down-regulating the IGF-1/PI3K/AKT pathway.
Wang J; Zhang Y; Dou Z; Jiang H; Wang Y; Gao X; Xin X
J Cell Mol Med; 2019 Aug; 23(8):5566-5575. PubMed ID: 31187582
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA miR-4779 suppresses tumor growth by inducing apoptosis and cell cycle arrest through direct targeting of PAK2 and CCND3.
Koo KH; Kwon H
Cell Death Dis; 2018 Jan; 9(2):77. PubMed ID: 29362401
[TBL] [Abstract][Full Text] [Related]
18. miR-217 and CAGE form feedback loop and regulates the response to anti-cancer drugs through EGFR and HER2.
Kim Y; Kim H; Park D; Han M; Lee H; Lee YS; Choe J; Kim YM; Jeoung D
Oncotarget; 2016 Mar; 7(9):10297-321. PubMed ID: 26863629
[TBL] [Abstract][Full Text] [Related]
19. The DDX6/KIFC1 signaling axis, as regulated by YY1, contributes to the malignant behavior of pancreatic cancer.
Deng X; Liu Z; Wang B; Ma J; Meng X
FASEB J; 2024 Apr; 38(7):e23581. PubMed ID: 38551642
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA MIAT promotes gastric cancer growth and metastasis through regulation of miR-141/DDX5 pathway.
Sha M; Lin M; Wang J; Ye J; Xu J; Xu N; Huang J
J Exp Clin Cancer Res; 2018 Mar; 37(1):58. PubMed ID: 29540201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
